Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2020 Publisher: Napp Pharmaceuticals Limited, Cambridge Science Park, Milton Road, Cambridge, CB4 0GW
DHC CONTINUS 60 mg, 90 mg and 120 mg prolonged release tablets.
| Pharmaceutical Form |
|---|
|
Prolonged release tablet. White capsule-shaped tablet. 60 mg tablets are marked DHC 60, 90 mg tablets are marked DHC 90 and 120 mg tablets are marked DHC 120. |
Each 60 mg tablet contains dihydrocodeine tartrate 60 mg.
Each 90 mg tablet contains dihydrocodeine tartrate 90 mg.
Each 120 mg tablet contains dihydrocodeine tartrate 120 mg.
Excipient with known effect:
Each 60 mg tablet contains lactose anhydrous 58.4 mg.
Each 90 mg tablet contains lactose anhydrous 40.5 mg.
Each 120 mg tablet contains lactose anhydrous 54 mg.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Dihydrocodeine |
Dihydrocodeine is a semisynthetic narcotic analgesic with a potency between morphine and codeine. It is also a centrally-acting anti-tussive. Dihydrocodeine works on the cough centre to lessen the incidence and intensity of coughing fits. |
| List of Excipients |
|---|
|
Lactose (anhydrous) |
Napp Pharmaceuticals Limited, Cambridge Science Park, Milton Road, Cambridge, CB4 0GW
PL 16950/0019
PL 16950/0020
PL 16950/0021
01 September 1999
ÂĐ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
